Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Panaji (Goa) [India], July 10 (ANI): Light to moderate rainfall spell is very likely to occur at many places over North Goa and South Goa districts during the next 3 hours, informed the India Meteorological Department (IMD).
Hyderabad (Telangana) [India], July 8 (ANI): Dr G Srinivas Rao, Telangana State Director of Health and Family Welfare (H&FW) has informed that COVID positive patients with moderate to severe symptoms can directly approach the Gandhi Hospital stating that the state government has made ela
Moscow [Russia], July 6 (ANI): Fueled by a Covid-19 triggered deep global recession, Russia's 2020 GDP growth is projected to contract by 6 per cent, an eleven-year low, with a moderate recovery in 2021-2022, according to the World Bank's latest Russia Economic Report released on Monday.
Pune (Maharashtra) [India], June 28 (ANI): Rain lashed parts of Pune on Sunday. India Meteorological Department (IMD) has predicted generally cloudy sky with moderate rain in the city for today.
New Delhi [India], June 27 (ANI): The Union Health Ministry has included the use of Dexamethasone as an alternative to Methylprednisolone for managing moderate to severe COVID-19 cases.
New Delhi [India], June 25 (ANI): Southwest Monsoon onset over Punjab has taken place on Thursday and the state is expected to get moderate to heavy rainfall at several places during the next three days, said Assistant Agrometeorologist Kulwinder Kaur Gill, Punjab Agriculture University.
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.